期刊文献+

氯沙坦治疗原发性高血压并高尿酸血症的临床研究 被引量:1

Clinical study of losartan treating primary hypertension associated with hyperuricemia
下载PDF
导出
摘要 目的研究氯沙坦治疗原发性高血压合并高尿酸血症的降压和降尿酸作用。方法选择60例原发性高血压合并高尿酸血症患者,随机分为两组,治疗组37例,给予氯沙坦50~100mg/d;对照组34例,给予依那普利10~20mg/d,观察用药4周前后血压与血尿酸的变化。结果两组降压效果均明显,治疗组能明显降低血尿酸,两组比较差异具有统计学意义。结论氯沙坦降压同时可降尿酸。 Objective To study the effects of losartan on hypertension and hyperuricemia. Methods Sixty patients with hypertension associated with hyperuricemia were elected and divided into two groups by random. Treating group included 37 patients took losartan 50 - 100mg/d. Control group included 34 patients took enalapril 10-20mg/d. The changes of blood pressure and level of uricacid in blood were recorded before and after treatment for 4 weeks. Results Blood pressure reduced apparently in the two group. The level of uricacid in blood reduced apparently in treating group. There was significant difference between the two groups. Conclu- sion Losartan can be used for reducing blood pressure and the level of uricacid in blood.
出处 《中原医刊》 2006年第21期26-27,共2页 Central Plains Medical Journal
关键词 氯沙坦 高血压 高尿酸血症 Losartan Hypertension Hyperuricemia
  • 相关文献

参考文献7

二级参考文献18

  • 1Keidar S, Attiac J, Smith J, et al. The angiotensin- Ⅱ receptor antagonist,losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice [J]. Biochem Biophys Res Commun,1997,236(3) :622.
  • 2DE Leon H,Wilcox JN,Ishizaka N, et al. A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells: Evidence for upregulation by angiotensin Ⅱ [J]. Arterioscler Thromb Vasc Biol,1995,15(1):42.
  • 3Haffner SM. Diabetes, hyperlipidemia and coronary artery disease[J]. Am J Cardliol, 1999,83(9) :17.
  • 4Mceneng J, Loughrey CM, Mcnamee PT, et al. Susceptibility of VLDL to oxidation in patients on regular haemodialysis[J]. Atherosclerosis, 1997,129(6) :215.
  • 5Bui MN, Sack MN, Moustatsos G, et al. Autoantibody tites to oxidized low density lipoprotein in patient with coronary atherosclerosis[J]. Am Heart J, 1996,131(5) :663.
  • 6Keidar S. Angiotensin, LDL peroxidafion and atherosclerosis[J]. Life Sci,1998,63(1) :1.
  • 7唐树德,上海医药,1995年,1卷,23页
  • 8刘乃丰 陈日新 等.ESR自旋捕集技术研究LDL氧化过程中的羟自由基[J].中国病理生理杂志,1994,10(6):631-634.
  • 9Choi Y,Chakraborty S.Pcrratublar capillary loss is associated with chronic tubulointerstilial injury in human kidney:altered expression of vascular endothelial growth factor.Human Pathol,2000,31(2):1491-1497.
  • 10Asami T,Nakano T,Sakai K,et al.Study on the relation between renal tubular disorders and glomerrular dysfunction in the early phase of insulin-dependent diabetes mellitus in children.Nippon Jinze Dakkai Shi,1992,34:57.

共引文献29

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部